Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

DTI & DIR in Optic Neuritis

NCT: NCT07748819 · NOT_YET_RECRUITING

NCT IDNCT07748819
StatusNOT_YET_RECRUITING
Start Date2026-08-01
Completion2028-06-30
SponsorAssiut University (OTHER)
First posted
Last updated

Brief Summary

To evaluate the role of Double Inversion Recovery (DIR) and Diffusion Tensor Imaging (DTI) in the assessment of optic neuritis and to correlate imaging findings with clinical and visual outcomes.

Frequently Asked Questions

What is DTI & DIR in Optic Neuritis?

DTI & DIR in Optic Neuritis is a clinical trial registered under NCT07748819. Current status: NOT_YET_RECRUITING.

What is the status of NCT07748819?

The current status of NCT07748819 (DTI & DIR in Optic Neuritis) is: NOT_YET_RECRUITING.

When did DTI & DIR in Optic Neuritis start?

DTI & DIR in Optic Neuritis started on 2026-08-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.